Respiratory Profile, Region 1, North Atlantic (CT, MA, ME, NJ, NH, NY, PA, RI, VT), Serum

Casandra

Casandra Test Code MC86078Version 1 (DRAFT)

Performing Lab

Lab Mayo Clinic LabLab Test ID RPR1CPT Codes 82785, 86003

Respiratory Profile, Region 1, North Atlantic (CT, MA, ME, NJ, NH, NY, PA, RI, VT), Serum

Clinical Use

Use

This test is useful for assessing sensitization to various inhalant allergens commonly found in the North Atlantic region, including Connecticut, Maryland, Maine, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont. It helps in defining the allergen responsible for eliciting signs and symptoms, identifying allergens responsible for allergic response or anaphylactic episode, confirming sensitization prior to beginning immunotherapy, and investigating the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens.

Special Instructions

For a listing of allergens available for testing, see [Allergens - Immunoglobulin E (IgE) Antibodies]. If not ordering electronically, complete, print, and send an [Allergen Test Request (T236)] with the specimen.

Limitations

This test is not useful for patients previously treated with immunotherapy to determine if residual clinical sensitivity exists or in whom the medical management does not depend upon identification of allergen specificity. Elevated concentrations of total IgE are not diagnostic for allergic disease, and results must be interpreted in the clinical context of the patient, including age, sex, travel history, potential allergen exposure, and family history. A normal concentration of total IgE does not eliminate the possibility of allergic disease.

Test Details

New York Approved

Methodology

Immunoassay (FEIA)

Biomarkers

26 targets

Alternaria Tenuis, IgEAspergillus Fumigatus, IgEBermuda Grass, IgEBox Eld/Maple, S, IgECat Epithelium, IgECladosporium, IgECockroach, IgECottonwood, IgE+18 more